Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marius M Hoeper

Showing results (291-300 of 311) with videos related to

Pageof 32
Sort By:
The European Respiratory Journal|December 18, 2020
ERS statement on chronic thromboembolic pulmonary hypertensionMarion Delcroix, Adam Torbicki, Deepa Gopalan, et al.
The Lancet. Respiratory Medicine|March 27, 2021
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trialMarius M Hoeper, Hikmet Al-Hiti, Raymond L Benza, et al.
Circulation|October 2, 2013
Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)Karen M Olsson, Marion Delcroix, H Ardeschir Ghofrani, et al.
Chest|February 6, 2021
Quality of Life 3 and 12 Months Following Acute Pulmonary Embolism: Analysis From a Prospective Multicenter Cohort StudyLuca Valerio, Stefano Barco, Marius Jankowski, et al.
European Journal of Heart Failure|March 16, 2023
European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of CardiologySuleman Aktaa, Chris P Gale, Margarita Brida, et al.
European Heart Journal|April 29, 2022
Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS studyLuca Valerio, Anna C Mavromanoli, Stefano Barco, et al.
Respiratory Medicine|February 4, 2021
Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registryHossein-Ardeschir Ghofrani, Miguel-Angel Gomez Sanchez, Marc Humbert, et al.
The European Respiratory Journal|October 22, 2021
Temporal trends in pulmonary arterial hypertension: results from the COMPERA registryMarius M Hoeper, Christine Pausch, Ekkehard Grünig, et al.
Frontiers in Cardiovascular Medicine|April 25, 2020
Comparison of MRI and VQ-SPECT as a Screening Test for Patients With Suspected CTEPH: CHANGE-MRI Study Design and RationaleFlorian Lasch, Annika Karch, Armin Koch, et al.
Respiratory Medicine|January 10, 2021
Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registryMarius M Hoeper, Miguel-Angel Gomez Sanchez, Marc Humbert, et al.
Pageof 32

Showing results (291-300 of 311) with videos related to

Sort By:
Pageof 32
The European Respiratory Journal|December 18, 2020
ERS statement on chronic thromboembolic pulmonary hypertensionMarion Delcroix, Adam Torbicki, Deepa Gopalan, et al.
The Lancet. Respiratory Medicine|March 27, 2021
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trialMarius M Hoeper, Hikmet Al-Hiti, Raymond L Benza, et al.
Circulation|October 2, 2013
Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)Karen M Olsson, Marion Delcroix, H Ardeschir Ghofrani, et al.
Chest|February 6, 2021
Quality of Life 3 and 12 Months Following Acute Pulmonary Embolism: Analysis From a Prospective Multicenter Cohort StudyLuca Valerio, Stefano Barco, Marius Jankowski, et al.
European Journal of Heart Failure|March 16, 2023
European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of CardiologySuleman Aktaa, Chris P Gale, Margarita Brida, et al.
European Heart Journal|April 29, 2022
Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS studyLuca Valerio, Anna C Mavromanoli, Stefano Barco, et al.
Respiratory Medicine|February 4, 2021
Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registryHossein-Ardeschir Ghofrani, Miguel-Angel Gomez Sanchez, Marc Humbert, et al.
The European Respiratory Journal|October 22, 2021
Temporal trends in pulmonary arterial hypertension: results from the COMPERA registryMarius M Hoeper, Christine Pausch, Ekkehard Grünig, et al.
Frontiers in Cardiovascular Medicine|April 25, 2020
Comparison of MRI and VQ-SPECT as a Screening Test for Patients With Suspected CTEPH: CHANGE-MRI Study Design and RationaleFlorian Lasch, Annika Karch, Armin Koch, et al.
Respiratory Medicine|January 10, 2021
Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registryMarius M Hoeper, Miguel-Angel Gomez Sanchez, Marc Humbert, et al.
Pageof 32